Get started
Author

Carsten Degenhart

Observed name: C. Degenhart
Observed institution: Lead Discovery Center (Germany)
OpenAlex ID: A5023986165
A Three-Hybrid Approach to Scanning the Proteome for Targets of Small Molecule Kinase Inhibitors
2004 · Frank Becker, Krishna Murthi, et al. · Chemistry & Biology · 139
PDF
A Novel CDK7 Inhibitor of the Pyrazolotriazine Class Exerts Broad-Spectrum Antiviral Activity at Nanomolar Concentrations
2015 · Corina Hutterer, Jan Eickhoff, et al. · Antimicrobial Agents and Chemotherapy · 102
Highly potent quinoxalinediones inhibit α-hemolysin and ameliorate Staphylococcus aureus lung infections
2025 · Aditya Shekhar, Raffaella Di Lucrezia, et al. · Cell Host & Microbe · 20
Profiling of ERBB receptors and downstream pathways reveals selectivity and hidden properties of ERBB4 antagonists
2024 · Lukša Popović, Jan P. Wintgens, et al. · iScience · 18
A bead-based GPCR phosphorylation immunoassay for high-throughput ligand profiling and GRK inhibitor screening
2022 · Johanna Kaufmann, Nina Kathleen Blum, et al. · Communications Biology · 15
PDF
Cytomegalovirus cyclin-dependent kinase ortholog vCDK/pUL97 undergoes regulatory interaction with human cyclin H and CDK7 to codetermine viral replication efficiency
2023 · Martin Schütz, Christina Wangen, et al. · Virus Research · 14
Pyrrolopyrimidine based CSF1R inhibitors: Attempted departure from Flatland
2023 · Frithjof Bjørnstad, Simen Havik, et al. · European Journal of Medicinal Chemistry · 7
A Reinvestigation of the Role of the Sorbic Acid Tail on the Antibacterial and Anti‐Tuberculosis Properties of Moiramide B
2023 · Irina Kollmorgen, Nathalie Bachmann, et al. · ChemMedChem · 5
PDF
Sequence‐Selective Covalent CaaX‐Box Receptors Prevent Farnesylation of Oncogenic Ras Proteins and Impact MAPK/PI3 K Signaling
2021 · Matthias Franz, Britta Mörchen, et al. · ChemMedChem · 4
PDF
Design and Synthesis of Pyridine-Based Pyrrolo[2,3-d]pyrimidine Analogs as CSF1R Inhibitors: Molecular Hybridization and Scaffold Hopping Approach
2025 · Srinivasulu Cherukupalli, Carsten Degenhart, et al. · Pharmaceuticals · 3
PDF
Synthesis, Biological Evaluation, and Binding Mode of a New Class of Oncogenic K‐Ras4b Inhibitors
2022 · Stephan Jeuken, Oleksandr Shkura, et al. · ChemMedChem · 2
PDF
Towards selective peptide deformylase inhibitors: A mass spectrometry-based evaluation of in cellulo activity of actinonin and bromoindole derivatives
2026 · Nathalie Bachmann, André Schultz, et al. · European Journal of Medicinal Chemistry · 1
Targeting EGFR Ex20 mutant lung cancer with the wild type sparing kinase inhibitor PRB001.
2019 · Martin L. Sos, Hannah Lea Tumbrink, et al. · Journal of Clinical Oncology · 1
An Imidazo[2,1‐b][1,3,4]thiadiazole Derivative Inhibits the Virulence Factor α‐Hemolysin by Blocking the Pullout of Its Stem Domain
2026 · Vadim S. Korotkov, Peer Lukat, et al. · ChemMedChem
A highly efficient access to new antibacterial actinonin derivatives via Ugi four-component reaction
2025 · Manuela Zouatom, Tianji Zhou, et al. · ChemRxiv
PDF
Evaluating Triazole-Substituted Pyrrolopyrimidines as CSF1R Inhibitors
2025 · Srinivasulu Cherukupalli, Jan Eickhoff, et al. · Molecules
PDF
340 (PB328): Discovery of NODX-010, a novel, potent PARG inhibitor demonstrating robust in vivo efficacy and the potential for new clinical settings that benefit patients with tumours resistant to PARP inhibitors
2024 · D. James, M. Debunne, et al. · European Journal of Cancer
Efficient characterization of kinase inhibitors using LeadCodeTM technology
2003 · Carsten Degenhart · Cellular & Molecular Biology Letters
Works count: 18
Citation count: 331
H-index: 7
I10-index: 6
Year
Topic
Type